Literature DB >> 29526166

Distinct genetic profiles of Leishmania (Viannia) braziliensis associate with clinical variations in cutaneous-leishmaniasis patients from an endemic area in Brazil.

Patrícia Flávia Quaresma1, Cristiana Ferreira Alves de Brito1, Jeronimo Marteleto Nunes Rugani1, Janaína de Moura Freire1, Rodrigo de Paula Baptista2, Elizabeth Castro Moreno3, Raquel Carvalho Gontijo1, Felipe Dutra Rego1, Joaquim Edemilson Diniz4, Maria Norma Melo3, Célia Maria Ferreira Gontijo1.   

Abstract

American tegumentary leishmaniasis (ATL) samples obtained from the lesions of patients with typical (n = 25, 29%), atypical (n = 60, 69%) or both (n = 2%) clinical manifestations were analysed by multilocus enzyme electrophoresis, hsp70 restriction-fragment length polymorphism (PCR-RFLP), hsp70 sequencing and phylogenetics methods. The hsp70 PCR-RFLP analysis revealed two different profiles whose the most samples differed from those expected for Leishmania braziliensis and the other Leishmania species tested: of 39 samples evaluated, two (5%) had a restriction profile corresponding to L. braziliensis, and 37 (95%) had a restriction profile corresponding to a variant pattern. A 1300-bp hsp70 gene fragment was sequenced to aid in parasite identification and a phylogenetic analysis was performed including 26 consensus sequences from the ATL patient's samples and comparing to other Leishmania and trypanosomatids species. The dendrogram allowed to observe a potential population structure of L. braziliensis complex in the studied region, emphasizing that the majority of clinical samples presented a variant genetic profile. Of interest, the L. braziliensis diversity was associated with different clinical manifestations whose parasites with hsp70 variant profile were associated with atypical lesions. The results may be helpful to improve the diagnosis, treatment and control measures of the ATL in endemic areas.

Entities:  

Keywords:  Atypical lesions; Brazil; Leishmania braziliensis; cutaneous leishmaniasis; hsp70 gene; parasite diversity

Mesh:

Substances:

Year:  2018        PMID: 29526166     DOI: 10.1017/S0031182018000276

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  12 in total

1.  Genetic variant strains of Leishmania (Viannia) braziliensis exhibit distinct biological behaviors.

Authors:  Felipe Dutra Rêgo; Ana Cristina Vianna Mariano da Rocha Lima; Agnes Antônia Sampaio Pereira; Patrícia Flávia Quaresma; Marcelo Antônio Pascoal-Xavier; Jeffrey Jon Shaw; Célia Maria Ferreira Gontijo
Journal:  Parasitol Res       Date:  2018-07-18       Impact factor: 2.289

2.  Leishmania braziliensis causing human disease in Northeast Brazil presents loci with genotypes in long-term equilibrium.

Authors:  Juliana A Silva; Ana Isabelle Pinheiro; Maria Luiza Dourado; Lilian Medina; Adriano Queiroz; Luiz Henrique Guimarães; Marcus Miranda Lessa; Ednaldo L Lago; Paulo Roberto L Machado; Mary E Wilson; Edgar M Carvalho; Albert Schriefer
Journal:  PLoS Negl Trop Dis       Date:  2022-06-15

3.  First Report of an Asymptomatic Leishmania (Viannia) shawi Infection Using a Nasal Swab in Amazon, Brazil.

Authors:  Luciana P Oliveira; Luciana C S Nascimento; Fabiola S Santos; Jaqueline L C Takamatsu; Luiz R P Sanchez; Walter S Santos; Lourdes M Garcez
Journal:  Int J Environ Res Public Health       Date:  2022-05-23       Impact factor: 4.614

Review 4.  Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs.

Authors:  Joice Castelo Branco Santos; Jonathas Alves de Melo; Sweta Maheshwari; Wendy Marina Toscano Queiroz de Medeiros; Johny Wysllas de Freitas Oliveira; Cláudia Jassica Moreno; L Mario Amzel; Sandra B Gabelli; Marcelo Sousa Silva
Journal:  Molecules       Date:  2020-06-03       Impact factor: 4.411

5.  Leishmania braziliensis: Strain-Specific Modulation of Phagosome Maturation.

Authors:  Tamara da Silva Vieira; Guillermo Arango Duque; Kévin Ory; Celia Maria Gontijo; Rodrigo Pedro Soares; Albert Descoteaux
Journal:  Front Cell Infect Microbiol       Date:  2019-09-06       Impact factor: 5.293

6.  Major changes in chromosomal somy, gene expression and gene dosage driven by SbIII in Leishmania braziliensis and Leishmania panamensis.

Authors:  Luz H Patino; Hideo Imamura; Lissa Cruz-Saavedra; Paula Pavia; Carlos Muskus; Claudia Méndez; Jean Claude Dujardin; Juan David Ramírez
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

7.  Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake.

Authors:  Jeronimo Nunes Rugani; Célia Maria Ferreira Gontijo; Frédéric Frézard; Rodrigo Pedro Soares; Rubens Lima do Monte-Neto
Journal:  Mem Inst Oswaldo Cruz       Date:  2019-08-15       Impact factor: 2.743

8.  Intraspecific Genomic Divergence and Minor Structural Variations in Leishmania (Viannia) panamensis.

Authors:  Luz H Patino; Marina Muñoz; Carlos Muskus; Claudia Méndez; Juan David Ramírez
Journal:  Genes (Basel)       Date:  2020-02-27       Impact factor: 4.096

9.  Genomic Diversification, Structural Plasticity, and Hybridization in Leishmania (Viannia) braziliensis.

Authors:  Luz H Patino; Marina Muñoz; Lissa Cruz-Saavedra; Carlos Muskus; Juan David Ramírez
Journal:  Front Cell Infect Microbiol       Date:  2020-10-16       Impact factor: 5.293

10.  A New Target Organ of Leishmania (Viannia) braziliensis Chronic Infection: The Intestine.

Authors:  Amanda Gubert Alves Dos Santos; Maria Gabriela Lima da Silva; Erick Lincoln Carneiro; Lainy Leiny de Lima; Andrea Claudia Bekner Silva Fernandes; Thaís Gomes Verzignassi Silveira; Debora de Mello Gonçales Sant'Ana; Gessilda de Alcantara Nogueira-Melo
Journal:  Front Cell Infect Microbiol       Date:  2021-07-14       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.